Progressive Care Inc. Announces Formation of RXMD Therapeutics Inc. Specializing in Cannabinoid-Based and Alternative Nutraceutical Products
01 oct. 2019 08h00 HE
|
Progressive Care, Inc.
MIAMI, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announces formation of its wholly owned subsidiary,...
Progressive Care Inc. Announces $3.7 Million Gross Revenue for August 2019
24 sept. 2019 08h00 HE
|
Progressive Care, Inc.
MIAMI, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced further growth year-over-year in revenue and...
Endonovo Therapeutics Announces Second Quarter Results
13 août 2019 13h39 HE
|
Endonovo Therapeutics Inc.
LOS ANGELES, Aug. 13, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), today announces financial and operating results for the...
Endonovo Therapeutics Announces National Rollout of SofPulse® Post-Operative Opioid Alternative into Hospitals
13 juin 2019 08h30 HE
|
Endonovo Therapeutics Inc.
WOODLAND HILLS, Calif., June 13, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive...
Progressive Care Inc. Issues 1st Quarter 2019 Quarterly Report Conference Call Highlights
16 mai 2019 08h00 HE
|
Progressive Care, Inc.
MIAMI, May 16, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today issued 1st Quarter 2019 Quarterly Report Conference Call...
MilanaPharm Receives Notice of Allowance from U.S. Patent Office For Lidocaine Topical Formulation
09 mai 2019 10h11 HE
|
MilanaPharm
TALLASSEE, Ala., May 09, 2019 (GLOBE NEWSWIRE) -- MilanaPharm, a specialty pharmaceutical company focused on the development of innovative, non-opioid pharmaceutical solutions for wound management...
MariMed Acquires Betty’s Eddies to Expand Precision Dosed Cannabis Product Lines
16 nov. 2017 08h15 HE
|
MariMed Inc.
NEWTON, Mass., Nov. 16, 2017 (GLOBE NEWSWIRE) -- MariMed Inc., (OTCQB:MRMD) today announced it has acquired the rights to the intellectual property (IP), formulations, recipes, proprietary...